Literature DB >> 22110295

Anaphylactic and anaphylactoid reactions during the perioperative period.

V Lagopoulos, E Gigi.   

Abstract

Anaphylactic reactions in the peri-operative period are often serious and potentially life-threatening conditions, involving multiple organ systems in which the clinical manifestations are the consequence of the release of preformed mediators from mast cells and basophils. Anaphylaxis is an immune mediated type I allergic reaction following the massive release of mediators from mast cells and basophils as a response to an allergen. Anaphylactoid reactions are defined as those reactions that produce the same clinical picture with anaphylaxis but are not IgE mediated, occur through a direct nonimmune-mediated release of mediators from mast cells and/or basophils or result from direct complement activation. The occurrence of these reactions during anesthesia, although quite rare, remains a major concern for the anesthesiologists. Thus, the need for systematic screening before surgery and the awareness and expert advice to anaesthesiologists seems to be very critical.

Entities:  

Keywords:  anaphylactoid reactions; anaphylaxis; perioperative period; review

Year:  2011        PMID: 22110295      PMCID: PMC3209676     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  14 in total

1.  Weal and flare responses to intradermal rocuronium and cisatracurium in humans.

Authors:  J H Levy; M Gottge; F Szlam; R Zaffer; C McCall
Journal:  Br J Anaesth       Date:  2000-12       Impact factor: 9.166

2.  Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway.

Authors:  A B Guttormsen
Journal:  Acta Anaesthesiol Scand       Date:  2001-11       Impact factor: 2.105

Review 3.  Anaphylaxis during the perioperative period.

Authors:  David L Hepner; Mariana C Castells
Journal:  Anesth Analg       Date:  2003-11       Impact factor: 5.108

Review 4.  Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention.

Authors:  M Fisher; B A Baldo
Journal:  Eur J Anaesthesiol       Date:  1994-07       Impact factor: 4.330

5.  Different patterns of mast cell activation by muscle relaxants in human skin.

Authors:  W Koppert; J A Blunk; L J Petersen; P Skov; K Rentsch; M Schmelz
Journal:  Anesthesiology       Date:  2001-09       Impact factor: 7.892

6.  [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)].

Authors:  P-M Mertes; M-C Laxenaire
Journal:  Ann Fr Anesth Reanim       Date:  2004-12

7.  Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study.

Authors:  Torkel Harboe; Anne Berit Guttormsen; Aagot Irgens; Turid Dybendal; Erik Florvaag
Journal:  Anesthesiology       Date:  2005-05       Impact factor: 7.892

8.  Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000.

Authors:  Paul Michel Mertes; Marie-Claire Laxenaire; François Alla
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

9.  Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.

Authors:  Wulf Dietrich; Anna Ebell; Raimund Busley; Anna-Laure Boulesteix
Journal:  Ann Thorac Surg       Date:  2007-10       Impact factor: 4.330

10.  Suspected anaphylactic reactions associated with anaesthesia.

Authors:  N J N Harper; T Dixon; P Dugué; D M Edgar; A Fay; H C Gooi; R Herriot; P Hopkins; J M Hunter; R Mirakian; R S H Pumphrey; S L Seneviratne; A F Walls; P Williams; J A Wildsmith; P Wood; A S Nasser; R K Powell; R Mirakhur; J Soar
Journal:  Anaesthesia       Date:  2009-02       Impact factor: 6.955

View more
  11 in total

1.  Life-threatening anaphylactic shock due to chlorhexidine on the central venous catheter: a case series.

Authors:  Meilin Weng; Minmin Zhu; Wankun Chen; Changhong Miao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  [Management of anaphylaxis. Part 1: Causes and pathophysiology].

Authors:  A Glowania; U Goebel; L Klimek
Journal:  HNO       Date:  2012-11       Impact factor: 1.284

3.  Suspected Anaphylactic Reaction to Ketamine in 3 Yucatan Swine (Sus scrofa).

Authors:  Chelsea K Wallace; Sara E Bell; Philip C LaTourette; Emily M Miedel; Anthony J Carty; Blythe H Philips
Journal:  Comp Med       Date:  2019-10-04       Impact factor: 0.982

4.  Severe (grade IV) hypersensitivity to iodinated contrast agent in an anesthetized dog.

Authors:  Karen L Basher; Ian R Porter; Manuel Martin-Flores
Journal:  Can Vet J       Date:  2019-07       Impact factor: 1.008

5.  The Three-Herb Formula Shuang-Huang-Lian stabilizes mast cells through activation of mitochondrial calcium uniporter.

Authors:  Yuan Gao; Rui Hou; Qiaoling Fei; Lei Fang; Yixin Han; Runlan Cai; Cheng Peng; Yun Qi
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

6.  Serious bronchospasm induced by cisatracurium besylate: A case report.

Authors:  Ning Wang; Yaozhong Zhang; Yu Hu; Qiyao Yang; Zhenbo Su
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

7.  A case report: anaphylaxis to cefazolin during renal transplant surgery.

Authors:  Kaveh Hemati; Shelley Gierat; Garrett R Roll; Odmara L Barreto Chang
Journal:  Allergy Asthma Clin Immunol       Date:  2021-05-29       Impact factor: 3.406

8.  The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis.

Authors:  Marharyta Sobczak; Rafał Pawliczak
Journal:  Clin Mol Allergy       Date:  2022-01-17

9.  Anaphylactoid reaction caused by sodium ceftriaxone in two horses experimentally infected by Borrelia burgdorferi.

Authors:  Roberta Carvalho Basile; Gabriela Gomes Rivera; Lara Antoniassi Del Rio; Talissa Camargo Mantovani de Bonis; Gabriel Paiva Domingues do Amaral; Edson Giangrecco; Guilherme Ferraz; Natalino Hajime Yoshinari; Paulo Aléscio Canola; Antonio Queiroz Neto
Journal:  BMC Vet Res       Date:  2015-08-12       Impact factor: 2.741

10.  Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs.

Authors:  Matthew J Krautmann; Sean Mahabir; Ann Fielder; Wendy Collard; Tracie L Wolthuis; Kevin Esch; Tracy Morton; Kent Alleman; Laibin Luo; Erin McCandless; Steven Nederveld; Kristina Kryda; Ryan Carroll; Joseph F Boucher
Journal:  Parasit Vectors       Date:  2019-09-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.